Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors

Plasma Insulin-Like Growth Factor 1 Is Associated with Cognitive Impairment in Parkinson's Disease

(2015) Jianfang Ma et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Serum insulin-like growth factor 1 and late-life depression: A population-based study

(2015) N.C. van Varsseveld et al.   PSYCHONEUROENDOCRINOLOGY

Neuroimaging biomarkers for Parkinson disease: Facts and fantasy

(2014) Joel S. Perlmutter et al.   ANNALS OF NEUROLOGY

A ‘bird’s eye’ view on the current status and potential benefits of blood biomarkers for Parkinson’s disease

(2014) Michelle M Mielke et al.   Biomarkers in Medicine

Normal age-dependent values of serum insulin growth factor-I: Results from a healthy Italian population

(2014) G. Aimaretti et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy

(2014) A. J. Westwood et al.   NEUROLOGY

Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays

(2014) Sebastian Heinzel et al.   PLoS One

Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults

(2013) Poul Frølund Vestergaard et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease

(2013) M. T. Pellecchia et al.   EUROPEAN JOURNAL OF NEUROLOGY

Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease

(2013) Marina Picillo et al.   JOURNAL OF NEUROLOGY

Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

(2013) Ayaka Numao et al.   PARKINSONISM & RELATED DISORDERS

Blood-based biomarkers for Parkinson's disease

(2013) Lama M. Chahine et al.   PARKINSONISM & RELATED DISORDERS

The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients

(2013) Roberto Erro et al.   PLoS One

Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease

(2012) Emmanuelle Duron et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The many faces of insulin-like peptide signalling in the brain

(2012) Ana M. Fernandez et al.   NATURE REVIEWS NEUROSCIENCE

Insulin-like growth factors in the brain and their potential clinical implications

(2012) E. E. Benarroch   NEUROLOGY

Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease

(2011) Jana Godau   ARCHIVES OF NEUROLOGY

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics

(2011) Manfred Gerlach et al.   JOURNAL OF NEURAL TRANSMISSION

Association Between Serum IGF-1 and Diabetes Among U.S. Adults

(2010) S. Teppala et al.   DIABETES CARE

Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson’s disease

(2010) Farhad Mashayekhi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease

(2010) J. Godau et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases

(2010) Walter Maetzler et al.   MOVEMENT DISORDERS

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Anthropometric Correlates of Insulin-Like Growth Factor 1 (IGF-1) and IGF Binding Protein-3 (IGFBP-3) Levels by Race/Ethnicity and Gender

(2009) Jessica M. Faupel-Badger et al.   ANNALS OF EPIDEMIOLOGY

Influence of Gender on Serum Growth Hormone, Insulin-Like Growth Factor-I and Its Binding Protein-3 during Aging

(2009) Chiou-Meei Lin et al.   YONSEI MEDICAL JOURNAL

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS